Living Cell Technologies Stock EBITDA
| LVCLF Stock | USD 0 0.00 0.00% |
Living Cell Technologies fundamentals help investors to digest information that contributes to Living Cell's financial success or failures. It also enables traders to predict the movement of Living Pink Sheet. The fundamental analysis module provides a way to measure Living Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Living Cell pink sheet.
Living |
Living Cell Technologies Company EBITDA Analysis
Living Cell's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Living Cell EBITDA | (2.38 M) |
Most of Living Cell's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Living Cell Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Living Cell Technologies reported earnings before interest,tax, depreciation and amortization of (2.38 Million). This is 100.27% lower than that of the Healthcare sector and 102.37% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.06% higher than that of the company.
Living EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Living Cell's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Living Cell could also be used in its relative valuation, which is a method of valuing Living Cell by comparing valuation metrics of similar companies.Living Cell is currently under evaluation in ebitda category among related companies.
Living Fundamentals
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (428.70) % | |||
| Current Valuation | 12.53 M | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 33.99 % | |||
| Price To Earning | (31.67) X | |||
| Price To Book | 6.96 X | |||
| Price To Sales | 5,587 X | |||
| Revenue | 3.4 K | |||
| Gross Profit | 3.4 K | |||
| EBITDA | (2.38 M) | |||
| Net Income | (1.96 M) | |||
| Cash And Equivalents | 4.24 M | |||
| Total Debt | 228.44 K | |||
| Debt To Equity | 0.10 % | |||
| Current Ratio | 17.84 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.04 M) | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 15 | |||
| Beta | 0.27 | |||
| Market Capitalization | 9.81 M | |||
| Total Asset | 4.27 M | |||
| Retained Earnings | (67 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 1000 K | |||
| Z Score | 5.4 | |||
| Net Asset | 4.27 M |
About Living Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Living Cell Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Living Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Living Cell Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Living Cell Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Living Pink Sheet analysis
When running Living Cell's price analysis, check to measure Living Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Living Cell is operating at the current time. Most of Living Cell's value examination focuses on studying past and present price action to predict the probability of Living Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Living Cell's price. Additionally, you may evaluate how the addition of Living Cell to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |